Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C
Korean J Hepatol. 2008;14(1):46-57.   Published online 2008 Mar 20     DOI: https://doi.org/10.3350/kjhep.2008.14.1.46
Citations to this article as recorded by Crossref logo
Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
Waranya Rattanavipapong, Thunyarat Anothaisintawee, Yot Teerawattananon, Jee-Fu Huang
PLOS ONE.2018; 13(2): e0193112.     CrossRef
Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia
Shiaw-Hooi Ho, Kee-Peng Ng, Harvinder Kaur, Khean-Lee Goh
Hepatobiliary & Pancreatic Diseases International.2015; 14(3): 281.     CrossRef
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park
Clinical and Molecular Hepatology.2013; 19(2): 148.     CrossRef
Systematic review: Asian patients with chronic hepatitis C infection
L. H. Nguyen, M. H. Nguyen
Alimentary Pharmacology & Therapeutics.2013; 37(10): 921.     CrossRef
Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
Soo Yong Park, Min Young Rim, In Ku Yo, Min Su Ha, Ju Seung Kim, Ji Won Lee, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Gastroenterology.2012; 60(5): 306.     CrossRef
Body Mass Index and Nonresponse to Antiviral Treatment in Korean Patients with Genotype 2 and 3 Chronic Hepatitis C
Yeon Joo Kim, Sung Bum Cho, Sang Woo Park, Hyoung Ju Hong, Du Hyeon Lee, Eun Ae Cho, HyunSoo Kim, Sung Kyu Choi, Jong Sun Rew
Chonnam Medical Journal.2012; 48(1): 21.     CrossRef
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clinical and Molecular Hepatology.2012; 18(3): 272.     CrossRef
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clinical and Molecular Hepatology.2012; 18(4): 360.     CrossRef
Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
Sang Hoon Park, Choong Kee Park, Jin Woo Lee, Young Seok Kim, Sook-Hyang Jeong, Yun Soo im, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang Chun Kyon Lee, Joo Hyun Sh
Gut and Liver.2012; 6(1): 98.     CrossRef
Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response
Su Rin Shin, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Cho, Joon Hyoek Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Journal of Gastroenterology and Hepatology.2010; 25(5): 957.     CrossRef
Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C
Philip Vutien, Nghia H Nguyen, Huy N Trinh, Jiayi Li, Ruel T Garcia, Gabriel Garcia, Khanh K Nguyen, Huy A Nguyen, Brian S Levitt, Emmet B Keeffe, Mindie H Nguyen
American Journal of Gastroenterology.2010; 105(5): 1110.     CrossRef
Treatment of chronic hepatitis C in Asia: When East meets West
Ming‐Lung Yu, Wan‐Long Chuang
Journal of Gastroenterology and Hepatology.2009; 24(3): 336.     CrossRef
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
Soung Won Jeong, Jin Dong Kim, Hyun Young Woo, Chan Ran You, Sung Won Lee, Myeong Jun Song, Jung Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
The Korean Journal of Hepatology.2009; 15(3): 338.     CrossRef
Current status of liver disease in Korea: Hepatitis C
Young-Suk Lim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S25.     CrossRef
Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
Myoung Joo Kang, Eun Uk Jung, Sang Won Park, Paul Choi, Ji Hyun Kim, Sung Jae Park, Eun Taek Park, Youn Jae Lee, Sang Hyuk Lee, Sang Yong Seol
The Korean Journal of Hepatology.2008; 14(3): 318.     CrossRef